Quantitative assessment of tumor metabolism using FDG-PET imaging
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 27 (7) , 683-687
- https://doi.org/10.1016/s0969-8051(00)00141-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Relevance of Positron Emission Tomography (PET) in OncologyStrahlentherapie und Onkologie, 1999
- Oncogenic alterations of metabolismTrends in Biochemical Sciences, 1999
- Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodulesBritish Journal of Surgery, 1998
- Insulin-induced hypoglycemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma.Radiology, 1997
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.Journal of Clinical Oncology, 1996
- Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.Radiology, 1995
- Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer, 1994
- Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.Journal of Clinical Oncology, 1993
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake DataJournal of Cerebral Blood Flow & Metabolism, 1983